Phase I/II trial of infusional vinorelbine in relapsed or refractory lymphoma.

被引：0
|
作者：
Sarris, AH
Psyrri, A
Romaguera, J
Hagemeister, F
McLaughlin, P
Bachier, C
Mesina, O
Adams, LM
Cabanillas, F
机构：
[1] Univ Texas, MD Anderson Cancer Ctr, Houston, TX 77030 USA
[2] Glaxo Wellcome Inc, Res Triangle Pk, NC 27709 USA
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2562
引用
收藏
页码：621A / 621A
页数：1
相关论文
共 50 条
  • [1] Phase II trial of GVDexa (gemcitabine, vinorelbine and dexamethasone) regimen in relapsed/refractory Hodgkin's lymphoma.
    Mehra, Nikita
    Ganesan, Prasanth
    Jayachandran, P. K.
    Joel, Anjana
    Karunakaran, Parathan
    Radhakrishnan, Venkatraman
    Ganesan, Trivadi S.
    Rathinam, Krishna
    Gnana, Sagar Tenali
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [2] Infusional vinorelbine in relapsed or refractory lymphomas
    Sarris, AH
    Psyrri, A
    Hagemeister, F
    Romaguera, J
    McLaughlin, P
    Rodriguez, MA
    Bachier, C
    Younes, A
    Mesina, O
    Oholendt, M
    Medeiros, LJ
    Samuels, B
    Adams, LM
    Cabanillas, F
    LEUKEMIA & LYMPHOMA, 2000, 39 (3-4) : 291 - 299
  • [3] A phase I/II trial of the combination of romidepsin and lenalidomide in patients with relapsed/refractory lymphoma and myeloma: Activity in T-cell lymphoma.
    Mehta-Shah, Neha
    Lunning, Matthew Alexander
    Boruchov, Adam M.
    Ruan, Jia
    Nair, Sumithra
    Lynch, Peggy
    Byrne, Regina
    Moskowitz, Alison J.
    Matasar, Matthew J.
    Gerecitano, John F.
    Hamlin, Paul A.
    Leonard, John
    Moskowitz, Craig H.
    Myskowski, Patricia L.
    Querfeld, Christiane
    Nolan, Patrick
    Palomba, Maria Lia
    Straus, David J.
    Zelenetz, Andrew David
    Horwitz, Steven M.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [4] Phase I/II clinical trial of ibrutinib and buparlisib in relapsed/refractory diffuse large B-cell lymphoma, mantle cell lymphoma, and follicular lymphoma.
    Batlevi, Connie Lee
    De Frank, Stephanie
    Stewart, Caitlin
    Hamlin, Paul A.
    Matasar, Matthew J.
    Gerecitano, John F.
    Moskowitz, Alison J.
    Hamilton, Audrey M.
    Zelenetz, Andrew David
    Drullinsky, Pamela
    Straus, David J.
    Kumar, Anita
    Moskowitz, Craig H.
    Dicostanzo, Joanna
    Callan, Devin
    Tsui, Dana
    Rademaker, Jurgen
    Schoder, Heiko
    Ni, Ai
    Younes, Anas
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [5] Phase II study of enzastaurin in the treatment of relapsed/refractory mantle cell lymphoma.
    Morschhausser, Frank
    Wolf, Martin
    Seymour, John
    Tilly, Herve
    Pfreundschuh, Michael
    Kluin-Nelemans, Hanneke
    Raemaekers, John
    van't Veer, Mars B.
    Milpied, Noel
    Cartron, Guillaume
    Pezzutto, Antonio
    Spencer, Andrew
    Darstein, Christelle
    Thornton, Donald
    Dreyling, Martin
    Reyes, Felix
    BLOOD, 2006, 108 (11) : 694A - 694A
  • [6] A Phase II Multicenter Study of Lenalidomide in Relapsed or Refractory Classical Hodgkin Lymphoma.
    Fehniger, Todd A.
    Larson, Sarah
    Trinkaus, Kathryn
    Siegel, Marilyn J.
    Cashen, Amanda F.
    Blum, Kristie A.
    Fenske, Timothy S.
    Hurd, David D.
    Goy, Andre
    DiPersio, John F.
    Bartlett, Nancy L.
    BLOOD, 2009, 114 (22) : 1422 - 1422
  • [7] OAsis: An international phase I trial of obinutuzumab, venetoclax plus ibrutinib in relapsed/refractory mantle cell lymphoma.
    Le Gouill, Steven
    Davies, Andrew
    Bouabdallah, Kamal
    Chiron, David
    Rule, Simon
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [8] Combination chemotherapy with gemcitabine and vinorelbine in the treatment of relapsed or refractory Diffuse Large B-cell Lymphoma. A phase II trial by the Hellenic Cooperative Oncology Group (HECOG).
    Papageorgiou, E
    Tsirigotis, P
    Dimopoulos, M
    Pavlidis, N
    Foutzilas, G
    Papageorgiou, S
    Economopoulos, T
    ANNALS OF ONCOLOGY, 2005, 16 : 220 - 220
  • [9] A Phase I/II Trial of Panobinostat in Combination With Lenalidomide in Patients With Relapsed or Refractory Hodgkin Lymphoma
    Maly, Joseph J.
    Christian, Beth A.
    Zhu, Xiaohua
    Wei, Lai
    Sexton, Jennifer L.
    Jaglowski, Samantha M.
    Devine, Steven M.
    Fehniger, Todd A.
    Wagner-Johnston, Nina D.
    Phelps, Mitch A.
    Bartlett, Nancy L.
    Blum, Kristie A.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (06): : 347 - 353
  • [10] Phase II Trial of Lenalidomide in Patients with Relapsed or Refractory Hodgkin Lymphoma
    Kuruvilla, John
    Taylor, Diane
    Wang, Lisa
    Blattler, Chantale
    Keating, Armand
    Crump, Michael
    BLOOD, 2008, 112 (11) : 1049 - 1049
12345